Stock Updates

Morning Stock Stories: Allergan plc (AGN)

Today’s top gainers include the company Allergan plc (NYSE:AGN) which is in the industry Drugs – Generic, gaining 0.97% today. In the last week its performance is 2.13%, and -3.17% for the past quarter. Currently, Allergan plc, AGN has a target price of 274.59, so today’s gain of 0.97% is a significant step towards its target price. The GAP today is therefore 0.25%.

Allergan plc (NYSE:AGN), has a market cap of 77.85 B, and is based in USA. Insider ownership is at 0.20%, and institutional ownership is 87.90%.

At the current price of 233.04, it has a dividend yield of 1.20%, and its target price is 274.59. This is with a profit margin of 80.50%, and total debt/equity of 0.45. Allergan plc (NYSE:AGN) has a P/E of *TBA, as well as a forward P/E of 12.97.

With a current EPS of -10.57, and a forecasted EPS growth for next year at 11.57%,Allergan plc (NYSE:AGN) has had a EPS growth for the past five years at -28.70%. For the next five years EPS growth is projected to be 12.38%.

Performance for the year is -4.53%. Since its IPO date on 2/17/1993, the total performance to date is 10.97%.

Volume today for Allergan plc (NYSE:AGN), is 2192748, while its average volume is 2358.1. Whilst the total gain today was 0.97%, it did have a day high of -5.60%.

Volatility for this week has been at 1.30%, and 1.27% for the month. The 52-week low for Allergan plc, AGN has been 26.31%, while the 52-week-high has reached -10.80%.

Looking at its return of investments, which is 0.10%, and its return on assets is 8.90%. Allergan plc (NYSE:AGN) has an operating margin of -17.40%. With a sales growth of 5.10% quarter over quarter. Bearing in mind that Allergan plc, AGN is in the sector Healthcare, its long-term debt/equity is 0.37, and has a current ratio of 1.3 and 1.2 for quick ratio.

So what is the value of Allergan plc? Well its PEG is *TBA, and the P/S is 5.28, along with a P/B of 1.11. Meanwhile it has a p/cash of 8.7.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment